Natalizumab treatment modulates Peroxisome Proliferator-Activated Receptors expression in women with multiple sclerosis

Peroxisome Proliferator-Activated Receptors (PPAR) are transcription factors suggested to be involved in inflammatory lesions of autoimmune encephalomyelitis and multiple sclerosis (MS). Our objective was to assess whether Natalizumab (NTZ) therapy is associated with alterations of PPAR expression i...

Full description

Bibliographic Details
Main Author: Ferret-Sena, Véronique (author)
Other Authors: Silva, Alexandra Maia e (author), Sena, Armando (author), Cavaleiro, Inês (author), Vale, José (author), Derudas, Bruno (author), Chinetti-Gbaguidi, Giulia (author), Staels, Bart (author)
Format: article
Language:eng
Published: 2017
Subjects:
Peroxisome Proliferator-Activated Receptors
Natalizumab
Multiple Sclerosis
Women
Online Access:http://hdl.handle.net/10400.26/19449
Country:Portugal
Oai:oai:comum.rcaap.pt:10400.26/19449

Internet

http://hdl.handle.net/10400.26/19449

Similar Items